AT2221
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AT2221, covering 2025-10-23 to 2025-10-23. Get the full timeline:
Most recent: Clinical Trial Update: First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221 [Phase 1, Phase 2]